Generic pharma plaintiffs say states’ Teva case should be among first tried
Shutterstock/Fahroni
Drug purchasers suing generic pharmaceutical companies for an alleged antitrust conspiracy have told a federal judge that the case brought by a large group of state attorneys general centred on Teva Pharmaceuticals should be among the first to go to trial.
Subscribe to Global Competition Review
Subscribe and start reading now
Global Competition Review (GCR) is the complete source of news and analysis for competition practitioners. It keeps you up to speed with the issues and trends that matter, giving you the detail, and depth, you need to operate successfully.
Subscribe now
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10